Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Canexil

Approved

STANDARD

Canexil

LifeSquare Laboratories, Inc🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: bf28d5a9e98a824d
Company: LifeSquare Laboratories, Inc
Type: Standard

Approval Details

Approval Id: bf28d5a9e98a824d
Drug Approval Philippines Name: Canexil
Product Name: Canexil
Registration Number: DRP-1225-07
Brand Name: Canexil
Generic Name: Cefalexin (as Monohydrate)
Dosage Form: Powder for Suspension
Dosage Strength: 100 mg / mL
Manufacturer: LifeSquare Laboratories, Inc
Distributor: Alman Pharmaceuticals, Inc
Issuance Date: 25 September 2024
Expiry Date: 19 January 2030
Pharmacologic Category: Antibacterial (Cephalosporin)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

bf28d5a9e98a824d

Type

Standard

Back to Philippines FDA Approvals

Canexil - Philippines FDA Drug Approval Details